An Internet newsletter devoted to the anti-obesity drug Acomplia can keep its Web site address now that it has settled with the drug's maker, Sanofi-Aventis SA. Medical Week News Inc. launched AcompliaReport.com last year to track the progress of the drug as it goes through clinic trials and awaits approval from the U.S. Food and Drug Administration. But Sanofi-Aventis asked an international arbitrator to force Medical Week to relinquish the site name, saying it could confuse the public.
November 11, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
An Internet newsletter devoted to the anti-obesity drug Acomplia can keep its Web site address now that it has settled with the drug’s maker, Sanofi-Aventis SA.
Medical Week News Inc. launched AcompliaReport.com last year to track the progress of the drug as it goes through clinic trials and awaits approval from the U.S. Food and Drug Administration. But Sanofi-Aventis asked an international arbitrator to force Medical Week to relinquish the site name, saying it could confuse the public.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
